tiprankstipranks
Trending News
More News >
Clearmind Medicine (CMND)
NASDAQ:CMND
US Market

Clearmind Medicine (CMND) Financial Statements

Compare
47 Followers

Clearmind Medicine Financial Overview

Clearmind Medicine's market cap is currently C$6.31M. The company's EPS TTM is $; its P/E ratio is ―; Clearmind Medicine is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Oct 23Oct 22Oct 21Oct 20Oct 19
Income Statement
Total Revenue
Gross Profit$ -96.42K$ -192.45K-$ -68.00K-
Operating Income$ -4.56M$ -6.64M$ -3.68M$ -233.22K$ -105.28K
EBITDA$ -6.16M$ -7.14M$ -3.90M$ -233.22K$ -105.28K
Net Income$ -6.23M$ -7.25M$ -3.90M$ -233.22K$ -105.28K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 5.95M$ 826.41K$ 5.16M$ 512.66K$ 178.38K
Total Debt$ 0.00$ 38.39K$ 0.00$ 0.00$ 0.00
Net Debt$ -5.51M$ -284.14K$ -4.60M$ -329.84K$ -688.00
Total Liabilities$ 4.97M$ 1.93M$ 357.15K$ 13.36K$ 44.57K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -4.56M-$ -2.84M$ -274.45K$ -73.01K
Operating Cash Flow$ -4.56M$ -3.72M$ -2.84M$ -264.45K$ -63.01K
Investing Cash Flow
Financing Cash Flow
Currency in USD

Clearmind Medicine Earnings and Revenue History

Clearmind Medicine Debt to Assets

Clearmind Medicine Cash Flow

Clearmind Medicine Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis